Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven R Jones

Showing results (91-100 of 146) with videos related to

Pageof 15
Sort By:
Archives of Medical Science : AMS|November 23, 2020
Modern prevalence of the Fredrickson-Levy-Lees dyslipidemias: findings from the Very Large Database of Lipids and National Health and Nutrition Examination SurveyVasanth Sathiyakumar, Vincent A Pallazola, Jihwan Park, et al.
Journal of Clinical Lipidology|June 27, 2018
Association between high-density lipoprotein subfractions and low-grade inflammation, insulin resistance, and metabolic syndrome components: The ELSA-Brasil studyGiuliano Generoso, Isabela M Bensenor, Raul D Santos, et al.
Mayo Clinic Proceedings|December 3, 2014
Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trialsMaciej Banach, Corina Serban, Amirhossein Sahebkar, et al.
Journal of Clinical Lipidology|August 1, 2015
Lipid phenotypes at the extremes of high-density lipoprotein cholesterol: The very large database of lipids-9Renato Quispe, Mohammed Al-Hijji, Kristopher J Swiger, et al.
Future Cardiology|February 26, 2016
PCSK9 inhibitors and their role in high-risk patients in reducing LDL cholesterol levels: alirocumabChanukya Dahagam, Aditya Goud, Abdelhai Abdelqader, et al.
European Heart Journal|August 31, 2018
Associations between very low concentrations of low density lipoprotein cholesterol, high sensitivity C-reactive protein, and health outcomes in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) studyPeter E Penson, D Leann Long, George Howard, et al.
Cardiovascular Drugs and Therapy|July 26, 2017
Efficacy and Safety of Alternate-Day Versus Daily Dosing of Statins: a Systematic Review and Meta-AnalysisKamal Awad, Dimitri P Mikhailidis, Peter P Toth, et al.
Future Cardiology|February 26, 2016
PCSK9 inhibitors and their role in high-risk patients in reducing LDL cholesterol levels: evolocumabChanukya Dahagam, Aditya Goud, Abdelhai Abdelqader, et al.
Diabetes & Vascular Disease Research|July 20, 2018
Diabetes alters the association between high-density lipoprotein subfractions and carotid intima-media thickness: The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)Giuliano Generoso, Isabela M Bensenor, Itamar S Santos, et al.
Journal of the American Heart Association|November 11, 2015
mActive: A Randomized Clinical Trial of an Automated mHealth Intervention for Physical Activity PromotionSeth S Martin, David I Feldman, Roger S Blumenthal, et al.
Pageof 15

Showing results (91-100 of 146) with videos related to

Sort By:
Pageof 15
Archives of Medical Science : AMS|November 23, 2020
Modern prevalence of the Fredrickson-Levy-Lees dyslipidemias: findings from the Very Large Database of Lipids and National Health and Nutrition Examination SurveyVasanth Sathiyakumar, Vincent A Pallazola, Jihwan Park, et al.
Journal of Clinical Lipidology|June 27, 2018
Association between high-density lipoprotein subfractions and low-grade inflammation, insulin resistance, and metabolic syndrome components: The ELSA-Brasil studyGiuliano Generoso, Isabela M Bensenor, Raul D Santos, et al.
Mayo Clinic Proceedings|December 3, 2014
Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trialsMaciej Banach, Corina Serban, Amirhossein Sahebkar, et al.
Journal of Clinical Lipidology|August 1, 2015
Lipid phenotypes at the extremes of high-density lipoprotein cholesterol: The very large database of lipids-9Renato Quispe, Mohammed Al-Hijji, Kristopher J Swiger, et al.
Future Cardiology|February 26, 2016
PCSK9 inhibitors and their role in high-risk patients in reducing LDL cholesterol levels: alirocumabChanukya Dahagam, Aditya Goud, Abdelhai Abdelqader, et al.
European Heart Journal|August 31, 2018
Associations between very low concentrations of low density lipoprotein cholesterol, high sensitivity C-reactive protein, and health outcomes in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) studyPeter E Penson, D Leann Long, George Howard, et al.
Cardiovascular Drugs and Therapy|July 26, 2017
Efficacy and Safety of Alternate-Day Versus Daily Dosing of Statins: a Systematic Review and Meta-AnalysisKamal Awad, Dimitri P Mikhailidis, Peter P Toth, et al.
Future Cardiology|February 26, 2016
PCSK9 inhibitors and their role in high-risk patients in reducing LDL cholesterol levels: evolocumabChanukya Dahagam, Aditya Goud, Abdelhai Abdelqader, et al.
Diabetes & Vascular Disease Research|July 20, 2018
Diabetes alters the association between high-density lipoprotein subfractions and carotid intima-media thickness: The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)Giuliano Generoso, Isabela M Bensenor, Itamar S Santos, et al.
Journal of the American Heart Association|November 11, 2015
mActive: A Randomized Clinical Trial of an Automated mHealth Intervention for Physical Activity PromotionSeth S Martin, David I Feldman, Roger S Blumenthal, et al.
Pageof 15